AG
DCPH

Advisor Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Advisor Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Buy
18
+6
+50% +$285 ﹤0.01% 5224
2019
Q3 		$0 Buy
+12
New +$355 ﹤0.01% 5466

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisor Group's DCPH Position: Q4 2019 in Review

Advisor Group increased its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 50% in Q4 2019, buying an estimated $285 and bringing the position to 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5224.

Advisor Group first reported a position in DCPH in Q3 2019 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold DCPH as of Q4 2019.

  • Advisor Group held 18 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $1K as of Q4 2019.
  • Advisor Group bought 6 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $285.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5224 holding.
  • Advisor Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.